Eradication of malaria through genetic engineering: the current situation

Area of Science:

• * Parasitology and Tropical Medicine
• * Genetics and Molecular Biology
• * Drug Resistance Mechanisms

Background:

• * Malaria, caused by the Plasmodium parasite, remains a significant global health burden, responsible for millions of deaths annually.
• * Host and parasite genetics play a critical role in malaria susceptibility and disease progression.
• * While vector control and artemisinin-based combination therapies have reduced malaria burden, emerging parasite and vector resistance threaten their efficacy.

Purpose of the Study:

• * To review mechanisms of anti-malarial drug resistance in Plasmodium parasites.
• * To discuss novel genetically engineered tools as research priorities for malaria eradication.
• * To examine challenges in translating transgenic interventions into functional products.

Main Methods:

• * Literature review of Plasmodium drug resistance mechanisms.
• * Analysis of current research on genetically engineered tools for malaria control.
• * Discussion of experimental, ethical, regulatory, and public acceptance hurdles for transgenic interventions.

Main Results:

• * Emergence of resistance in Plasmodium parasites and mosquitoes to current antimalarial drugs is a critical concern.
• * Genetically engineered tools offer potential for novel interventions against malaria.
• * Significant challenges exist in the development and implementation of these advanced tools, including regulatory and public acceptance issues.

Conclusions:

• * Addressing Plasmodium drug resistance is paramount for effective malaria control.
• * Further research and development of genetically engineered interventions are crucial for global malaria eradication.
• * Overcoming multifaceted hurdles is essential to translate scientific advancements into practical malaria control strategies.